drugset / Trial / NCT00309517

Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C

NCT00309517 ↗

Phase 3 Terminated 700 enrolled Austrian Breast & Colorectal Cancer Study Group
RandomizedParallel-groupOpen-labelTreatment

Summary

This clinical investigation examined the influence of preoperative radiotherapy in combination with postoperative 5-fluorouracil + leucovorin chemotherapy vs. 5-fluorouracil + leucovorin + MAb 17-1A chemo-immunotherapy on patients' local recurrence rate and overall survival time following surgery for rectal carcinoma Dukes B or C (T2-4, N0-3, M0).

Timeline

Start
1997-07
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject edrecolomab Monoclonal antibody — —
Background Fluourouracil Unknown — —
Background Leucovorin Small molecule — —

Indications